TRANSFORMING HEALTHCARE TOGETHER
“Genomics plc’s platform unlocks knowledge from population-scale genetics to make drug discovery and development more efficient. Peter Donnelly, a world-class scientist in this field, has built a stellar team of scientists and engineers, and we look forward to seeing what they will accomplish for patients in the UK and around the world.”
“Human biology and genetics are a foundation of drug discovery at Vertex and the team at Genomics plc brings together a unique combination of sophisticated data science and human genetics. Our partnership with Genomics plc pioneers new uses of genomic tools and technologies to advance Vertex’s ongoing work and investment at our Oxford Research Site and globally to bring new medicines to the patients that need them.”
“The world-class team at Genomics plc have made great strides since the company’s inception. Genomics has the potential to improve the quality of delivery of health care and have significant impact on the development of breakthrough drugs.”
What if you could give your policyholders the most precious gift of all – the opportunity to live their longest, healthiest life? We use the most advanced polygenic risk scores and data science at the edge to predict an individual's risk of common diseases – all with a single at-home test.
Our platform provides employees with the personalised tools and guidance to put them on a healthier trajectory and increase their quality of life. That’s good news for your employees, and great news for you.
From accelerating drug discovery to optimising clinical trial design and post-market studies, we help pharma companies deliver more targeted therapeutics with increased efficiency, safety and efficacy.
From individuals to populations, our industry-leading genetic risk prediction and stratification tools enable the delivery of more personalised, precision health.
We were formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford. Today, we are collaborating with some of the world’s leading healthcare and life science organisations, helping them to predict, to prevent, to treat, to cure – dramatically reducing the human and financial cost of common diseases like cancer, diabetes and heart disease.
